Kitsune Biotherapeutics, a CU spinout company, uses machine learning and novel chemistry to create shape-shifting cyclic peptides that increase cell permeability to affect challenges intracellular tar ...

Long investor

Kerna Ventures is an early-stage, academia-rooted, geo-agnostic VC firm investing seed through Series A in advanced therapeutic platform technologies in genetic medicine, targeted delivery and advance ...

Kernal Bio is VC-backed biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted deliver ...

Kesmalea is developing orally available, CNS penetrant targeted protein degraders. We are backed by Syncona and OSE. Kesmalea’s SELFTAC® platform is a widely applicable solution to the “size problem” ...

Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. H ...

The Next Trillion DollarRevolution Isn’t Digital.... It’s Biological, And It Starts With Real-Time Human ISF Access​KIFFIK Biomedical is pioneering interstitial fluid (ISF)-based diagnostics, transfor ...

KYAN Technologies is leading the way in functional precision medicine and tackling the complexity of cancer by integrating small data AI and ex-vivo biological experiments.

KALIVIR is a clinical-stage biopharmaceutical company dedicated to developing systemically deliverable oncolytic virus immunotherapies.